IPOs

Si-Bone closes $124m IPO
Si-Bone closes $124m IPO
Mass Device
SI-BONE
IPOs
devices
Flag link:
Vapotherm registers $58m IPO
Vapotherm registers $58m IPO
Mass Device
Vapotherm
IPOs
devices
Precision Flow
Flag link:
Novartis in constant evolution: new large investment in startup
Novartis in constant evolution: new large investment in startup
GoinPharma
Gamida Cell
IPOs
Novartis
NiCord
Flag link:
PhaseBio, Osmotica price IPOs well below range
PhaseBio, Osmotica price IPOs well below range
BioCentury
PhaseBio
Osmotica Pharmaceuticals
IPOs
Flag link:
Innovent Biologics Plans Hong Kong IPO to Raise $423 Million, Despite Global Downturn
Innovent Biologics Plans Hong Kong IPO to Raise $423 Million, Despite Global Downturn
Biopharma Dive
IPOs
Innovent Biologics
Hong Kong
Flag link:
BioSpace's List of Q4 2018 Life Sciences IPOs
BioSpace's List of Q4 2018 Life Sciences IPOs
BioSpace
biotech
IPOs
Flag link:
Hoth Therapeutics seeks IPO cash to battle eczema
Hoth Therapeutics seeks IPO cash to battle eczema
Fierce Biotech
Hoth Therapeutics
IPOs
NASDAQ
eczema
Flag link:
Allogene raises $324M in year's largest biotech IPO on NASDAQ
Allogene raises $324M in year's largest biotech IPO on NASDAQ
BioCentury
Allogene
IPOs
cell therapy
NASDAQ
Flag link:
4 Reasons to Be Wary of This Animal Health IPO
4 Reasons to Be Wary of This Animal Health IPO
Motley Fool
Elanco
IPOs
Eli Lilly
animal health
Flag link:
Axonics Modulation files for $86m IPO
Axonics Modulation files for $86m IPO
Mass Device
devices
IPOs
Axonics
neuromodulation
Flag link:
Peninsula biotech coughs up 40 percent of its value on failed clinical trial
Peninsula biotech coughs up 40 percent of its value on failed clinical trial
Bizjournals.com
clinical trials
IPOs
Menlo Therapeutics
serlopitant
Flag link:
Orchard Therapeutics proposes IPO
Orchard Therapeutics proposes IPO
BioCentury
Orchard Therapeutics
IPOs
Flag link:
Allogene IPO could be year's largest biotech listing on NASDAQ
Allogene IPO could be year's largest biotech listing on NASDAQ
BioCentury
IPOs
NASDAQ
Allogene
CAR-T
Flag link:
Israel-Based Gamida Cell Files for $69 Million IPO
Israel-Based Gamida Cell Files for $69 Million IPO
BioSpace
Gamida Cell
IPOs
Israel
NASDAQ
Flag link:
Gritstone raises $100M in upsized IPO
Gritstone raises $100M in upsized IPO
BioCentury
Gritsone Oncology
IPOs
Flag link:
Nasdaq triple IPO play brings in $345M as the big biotech party rocks on
Nasdaq triple IPO play brings in $345M as the big biotech party rocks on
Endpoints
NASDAQ
IPOs
Entasis
Urovant Sciences
Arvinas
Sutro BioPharma
Flag link:
Entasis dips in first trading day after $75M IPO
Entasis dips in first trading day after $75M IPO
BioCentury
IPOs
AstraZeneca
Entasis
Flag link:
PhaseBio details dollars in AstraZeneca deal as it rolls out a plan for $86M-plus IPO
PhaseBio details dollars in AstraZeneca deal as it rolls out a plan for $86M-plus IPO
Endpoints
PhaseBio
IPOs
PB2452
anti-anti-coagulants
AstraZeneca
Flag link:
Equillium Plans IPO to Fund Clinical Trials for Transplant Drug
Equillium Plans IPO to Fund Clinical Trials for Transplant Drug
Xconomy
Equillium
IPOs
organ transplants
Flag link:
Y-mAbs raises $96M in upsized IPO
Y-mAbs raises $96M in upsized IPO
BioCentury
Y-mAbs
IPOs
Flag link:

Pages